Back to Search
JEDD WOLCHOK, MD
MD
Medical Oncology Physician
NPI: 1568433290IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
201197(NY)
Education
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
Class of 1994
Research & Publications (20)
The mechanism of anti-CTLA-4 activity and the negative regulation of T-cell activation.
PMID 19001145·Oncologist·2008
6-review
Safety and immunogenicity of tyrosinase DNA vaccines in patients with melanoma.
PMID 17726460·Mol Ther·2007
2-rct
Reassessing the usual suspects causing a commotion in the blood (and vessels?).
PMID 14739778·Cancer Biol Ther·2004
6-review
DNA vaccines: an active immunization strategy for prostate cancer.
PMID 14571413·Semin Oncol·2003
6-review
Phase I trial of high dose paracetamol and carmustine in patients with metastatic melanoma.
PMID 12690304·Melanoma Res·2003
3-trial
Alternative roles for interferon-gamma in the immune response to DNA vaccines encoding related melanosomal antigens.
PMID 12747770·Cancer Immun·2001
7-preclinical
Vaccines for melanoma: translating basic immunology into new therapies.
PMID 11905765·Lancet Oncol·2001
6-review
Development of effective vaccines for old mice in a tumor model.
PMID 19103244·Vaccine·2009
7-preclinical
OX40 engagement and chemotherapy combination provides potent antitumor immunity with concomitant regulatory T cell apoptosis.
PMID 19414558·J Exp Med·2009
7-preclinical
Self-antigen-specific CD8+ T cell precursor frequency determines the quality of the antitumor immune response.
PMID 19332877·J Exp Med·2009
7-preclinical
Direct economic burden of high-risk and metastatic melanoma in the elderly: evidence from the SEER-Medicare linked database.
PMID 19558193·Appl Health Econ Health Policy·2009
8-other
Safety and immunogenicity of a human and mouse gp100 DNA vaccine in a phase I trial of patients with melanoma.
PMID 19496531·Cancer Immun·2009
3-trial
Keratinocyte growth factor enhances DNA plasmid tumor vaccine responses after murine allogeneic bone marrow transplantation.
PMID 19011222·Blood·2009
7-preclinical
The effect of bioreactor induced vibrational stimulation on extracellular matrix production from human derived fibroblasts.
PMID 18937972·Biomaterials·2009
8-other
Phase II trial of 17-allylamino-17-demethoxygeldanamycin in patients with metastatic melanoma.
PMID 19088048·Clin Cancer Res·2008
3-trial
CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit.
PMID 19074257·Proc Natl Acad Sci U S A·2008
3-trial
Improved tumor immunity using anti-tyrosinase related protein-1 monoclonal antibody combined with DNA vaccines in murine melanoma.
PMID 19047169·Cancer Res·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1275 YORK AVE
NEW YORK, NY 10021 - Phone
- (646) 227-3813
Quick Facts
- NPI
- 1568433290
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 32
- Publications
- 20
Are you this provider?
Claim Your Profile